Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: IXICO plc

Market Cap 18.86M 25.32M 21.87M 20.15M 35.35M 2.41B 35.89M 238M 92.76M 1.17B 95.01M 92.99M 4.06B P/E Ratio 2026 *
-5.41x
P/E Ratio 2027 * -6.65x
Enterprise Value 9.26M 12.43M 10.74M 9.89M 17.36M 1.18B 17.62M 117M 45.55M 575M 46.65M 45.66M 1.99B EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.46x
Free-Float
89.2%
Yield 2026 *
-
Yield 2027 * -
1 month+28.15%
3 months+10.90%
6 months-29.39%
Current year-26.38%
1 week 8.3
Extreme 8.3
8.84
1 month 6.26
Extreme 6.26
9
Current year 6.26
Extreme 6.26
12
1 year 6.26
Extreme 6.26
15
3 years 6.26
Extreme 6.26
21
5 years 6.26
Extreme 6.26
92
10 years 6.26
Extreme 6.26
127
Manager TitleAgeSince
Chief Executive Officer 53 2024-08-18
Director of Finance/CFO 50 2019-08-20
Chief Tech/Sci/R&D Officer - 2025-05-31
Director TitleAgeSince
Chairman 51 -
Director/Board Member 62 2023-10-04
Director/Board Member 50 2019-08-20
Date Insider Type Main position Quantity % Market Cap.
25-06-12Buy

Chief Financial Officer

45,263 0.0488%
25-06-12Free 350,000 0.3777%
25-06-12Free 350,000 0.3777%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00%-29.39%-52.60% 25.16M
-0.35%+0.97%-15.96%-12.73% 42.96B
+2.90%+3.07%+274.14%+507.70% 31.73B
-0.20%-1.41%+13.66%-14.65% 30.22B
+1.74%-2.15%-4.42%+23.97% 28.94B
+4.09%-1.98%+11.99%+17.37% 23.87B
-1.42%+3.19%+54.19%+115.00% 13.57B
-0.40%-1.48%+7.48%+7.12% 12.96B
+2.32%+4.98% - - 13.39B
-0.99%-1.79%+105.35%+75.70% 12.2B
Average +0.73%-0.65%+46.34%+74.10% 20.98B
Weighted average by Cap. +0.95%-1.09%+54.46%+95.70%

Financials

2026 *2027 *
Net sales 7.5M 10.07M 8.69M 8.01M 14.06M 957M 14.27M 94.61M 36.89M 466M 37.78M 36.98M 1.61B 9M 12.08M 10.43M 9.61M 16.87M 1.15B 17.13M 114M 44.26M 559M 45.34M 44.37M 1.94B
Net income -2.4M -3.22M -2.78M -2.56M -4.5M -306M -4.57M -30.27M -11.8M -149M -12.09M -11.83M -516M -2.8M -3.76M -3.25M -2.99M -5.25M -357M -5.33M -35.32M -13.77M -174M -14.11M -13.8M -602M
Net Debt -9.6M -12.89M -11.13M -10.26M -17.99M -1.22B -18.27M -121M -47.22M -596M -48.36M -47.33M -2.06B -5.7M -7.65M -6.61M -6.09M -10.68M -727M -10.85M -71.9M -28.03M -354M -28.71M -28.1M -1.23B
Logo IXICO plc
IXICO plc is engaged in neuroscience imaging and biomarker analytics, using its artificial intelligence (AI)-driven platform to help advance drug development in neurological disorders. The Company is engaged in delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. It advances medicine and human health by turning data into clinically meaningful information, providing new insights in neuroscience by supporting pharmaceutical companies across all phases of central nervous system (CNS) clinical research. Its services include imaging biomarkers, trial management, data analytics, consultancy and post-marketing surveillance. Its TrialTracker platform provides a standardized, compliant and efficient workflow for capturing visual read results of MRI, SPECT, PET and CT scans, supporting single, over-read and double adjudicated read paradigms.
Employees
79
Date Price Change Volume
26-06-12 8.650 p 0.00% 52,900
26-06-11 8.650 p 0.00% 6,798
26-06-10 8.650 p 0.00% 18,439
26-06-09 8.650 p 0.00% 6,980
26-06-08 8.650 p 0.00% 3,865
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.0865GBP
Average target price
0.2600GBP
Spread / Average Target
+200.58%

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!